VivoSim Labs, Inc. VIVS
0.22
(0.01)
(4.35%)
as of 25 Sep
- Market cap
- $3.9M
- P/E
- 0.0×
Follow VIVS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.96 | 4.67 |
+8 more quarters Free account |
P/S ratio |
50.05 | 28.25 | 33.24 | 54.33 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1.74) | (1.65) | (2.08) | (3.20) | |
P/B ratio |
0.00 | 0.00 | 1.06 | 1.08 | |
Price to Tangible BV |
0.00 | 0.00 | 1.06 | 1.08 | |
EV/Sales |
35.15 | (10.09) | 3.05 | 6.65 | |
EV/EBITDA |
0.00 | 0.12 | 0.00 | 0.00 | |
EV/Operating CF |
(0.39) | 0.12 | (0.04) | (0.09) | |
EV/FCF |
(3.26) | 0.69 | (0.25) | (0.75) | |
Quick Ratio |
1.43 | 2.18 | 2.15 | 2.74 | |
Current Ratio |
1.70 | 2.38 | 2.44 | 3.10 | |
Net Debt/EBITDA |
0.61 | 1.60 | 1.59 | 2.59 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.01 | 0.01 | 0.03 | 0.02 | |
Operating CF/Net income |
2.40 | 0.39 | 0.84 | 0.93 | |
Capex/Depreciation |
(0.57) | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6,288.89% | 2,812.50% | 4,384.62% | 3,296.43% | |
Selling, General and Administrative Expense of Revenue |
9,138.89% | 5,255.00% | 6,292.31% | 6,214.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
505.56% | 215.00% | 257.69% | 257.14% | |
Graham Net Nets |
(0.53) | (0.50) | 0.75 | 0.65 | |
Graham Number |
6.71 | 7.16 | 8.48 | 6.18 | |
Earnings Yield |
(417.76%) | (374.83%) | 103.69% | 21.43% | |
Free Cash Flow Yield |
(21.51%) | (51.61%) | (36.16%) | (16.26%) | |
Revenue per Share |
0.00 | 0.02 | 0.01 | 0.01 | |
Operating CF per Share |
(0.61) | (0.86) | (0.87) | (0.91) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.62) | (0.86) | (0.87) | (0.91) | |
Cash per Share |
0.32 | 1.94 | 1.64 | 2.56 | |
Shareholders Equity per Share |
(0.45) | (0.42) | 1.70 | 2.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.45) | (0.42) | 1.70 | 2.71 | |
Free Cash Flow |
(3.24) | (2.24) | (2.27) | (2.38) | |
Working Capital |
1.33 | 3.84 | 3.57 | 5.14 | |
Capital Expenditures |
(0.02) | — | — | — | |
Net Current Asset Value |
(2.97) | (1.86) | 3.52 | 4.97 | |
EV/EBIT |
0.00 | 0.12 | 0.00 | 0.00 | |
Capex to Sales |
1.28 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(7,433.33%) | (14,410.00%) | (10,350.00%) | (9,089.29%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.54 | 0.54 | 0.54 | 0.03 | |
Average Payables |
0.65 | 1.33 | 0.80 | 0.50 | |
Average Assets |
7.91 | 11.02 | 5.40 | 8.22 | |
Average Common Equity |
3.60 | 4.70 | 2.40 | 5.37 |
Columns are period end dates